Conversion of aristeromycin into cyclaradine
US4740598A · kind A · utility
2Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 1986 |
| Grant date | Apr 26, 1988 |
| Priority date | — |
| Expiry date | May 20, 2006 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A process for the conversion of aristeromycin into cyclaradine via. The stereoselective reduction of a 3',5'-di-O-protected-2'-keto derivative of aristeromycin is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.